A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin ...

Isomorphic Labs, backed by Google's parent company Alphabet, is preparing for its first human clinical trials for cancer drugs designed entirely by artificial intelligence.

The company was spun out of Google DeepMind in 2021, and is built on the breakthrough ... In a recent interview with Fortune, Isomorphic Labs President Colin Murdoch said the company is “very close” ...

Meta Platforms is racing to secure top artificial intelligence talent for its newly created Superintelligence Labs to better ...

A Isomorphic Labs, a drug discovery company driven by artificial intelligence (IA) and part of the A (holding of Google), is ...

Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ...